
Stryker Corp
NYSE:SYK

Stryker Corp
Revenue
Stryker Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
![]() |
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
![]() |
Boston Scientific Corp
NYSE:BSX
|
Revenue
$17.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
Revenue
$5.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
![]() |
Abbott Laboratories
NYSE:ABT
|
Revenue
$42.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
Stryker Corp
Revenue Breakdown
Breakdown by Geography
Stryker Corp
Total Revenue:
22.6B
USD
|
United States:
16.9B
USD
|
International:
5.7B
USD
|
Europe, Middle East, Africa:
2.9B
USD
|
Breakdown by Segments
Stryker Corp
Total Revenue:
22.6B
USD
|
Medsurg And Neurotechnology:
13.5B
USD
|
Orthopaedics:
9.1B
USD
|
Stryker Corp
Glance View
Stryker Corporation, a pioneering force in the medical technology industry, traces its roots back to the innovative spirit of Dr. Homer Stryker, an orthopedic surgeon whose dissatisfaction with existing medical equipment spurred him to improve them. Founded in 1941, the company initially focused on new medical devices that addressed specific problems faced by healthcare practitioners. Over the decades, Stryker has evolved into a diversified powerhouse with a portfolio that spans a wide range of products, including joint replacements, surgical equipment, neurotechnology, and spine care solutions. This evolution came through strategic acquisitions and relentless innovation, allowing Stryker to meet the ever-increasing demands of a dynamic healthcare landscape. The company's business model thrives at the intersection of technology and healthcare. With their cutting-edge research and development capabilities, Stryker consistently pushes the envelope in creating sophisticated products that enhance patient outcomes. Revenue streams are predominantly generated from the sale of medical and surgical equipment as well as a myriad of implantable surgical devices used in orthopedic procedures. Stryker’s instruments and solutions are staples in hospitals and clinics worldwide, driven by their commitment to quality and efficacy. Additionally, the company's astute investments in advanced robotics and digital health technologies have positioned it well within the burgeoning field of precision medicine, providing lucrative opportunities to deepen its market entrenchment and expand its competitive edge.

See Also
What is Stryker Corp's Revenue?
Revenue
22.6B
USD
Based on the financial report for Dec 31, 2024, Stryker Corp's Revenue amounts to 22.6B USD.
What is Stryker Corp's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Stryker Corp have been 10% over the past three years , 9% over the past five years , and 9% over the past ten years .